Concepedia
Statistics
Publications
44
Citations
3.1K
H-Index
25
Active since
2000
Affiliations
National Cancer Institute(Current)
National Institutes of Health
Memorial Sloan Kettering Cancer Center
Center for Cancer Research
Sylvester Comprehensive Cancer Center
Dickran Kazandjian is an author at National Cancer Institute specializing in medicine, hematology, and pathology.
Top concepts
MedicineOncologyPathologyHematologyCancer ResearchImmunologyImmunotherapyTumor MicroenvironmentMolecular DiagnosticsHealth
Publications per year
2000–2024
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
Dickran Kazandjian, Daniel L. Suzman, Gideon M. Blumenthal et al. · The Oncologist · 2016 · 473 citations · Full text
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 308 citations · Full text
FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements
Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen et al. · The Oncologist · 2014 · 283 citations · Full text
Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer
Dickran Kazandjian, Yutao Gong, Patricia Keegan et al. · JAMA Oncology · 2019 · 249 citations · Full text
Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer
Ewy A. Mathé, Andrew D. Patterson, Majda Haznadar et al. · Cancer Research · 2014 · 180 citations · Full text
1–5 of 44